Stuart Walter Peltz, Chief Executive Officer at PTC THERAPEUTICS, INC. (PTCT), sold 27,170 shares at $61.83 ($1.7M) on 2020-12-07, disclosed to the SEC on 2020-12-09.
Open-market sale of $1.7M PTCT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.52 | 815 | $49K | 2.9% |
| 2 | $59.52 | 1,255 | $75K | 4.5% |
| 3 | $59.52 | 1,255 | $75K | 4.5% |
| 4 | $59.56 | 3,090 | $184K | 11.1% |
| 5 | $59.56 | 3,090 | $184K | 11.1% |
| 6 | $59.57 | 2,808 |
| $167K |
| 10.1% |
| 7 | $59.57 | 2,808 | $167K | 10.1% |
| 8 | $60.68 | 400 | $24K | 1.5% |
| 9 | $60.72 | 1,100 | $67K | 4.0% |
| 10 | $60.87 | 1,200 | $73K | 4.4% |
| 11 | $60.95 | 600 | $37K | 2.2% |
| 12 | $61.83 | 1,300 | $80K | 4.9% |
| 13 | $61.88 | 449 | $28K | 1.7% |
| 14 | $61.89 | 400 | $25K | 1.5% |
| 15 | $61.93 | 1,200 | $74K | 4.5% |
| 16 | $62.47 | 100 | $6K | 0.4% |
| 17 | $63.21 | 400 | $25K | 1.5% |
| 18 | $64.01 | 500 | $32K | 1.9% |
| 19 | $64.16 | 1,200 | $77K | 4.7% |
| 20 | $64.41 | 1,600 | $103K | 6.2% |
| 21 | $64.42 | 500 | $32K | 1.9% |
| 22 | $64.71 | 300 | $19K | 1.2% |
| 23 | $64.82 | 700 | $45K | 2.7% |
| 24 | $65.12 | 100 | $7K | 0.4% |
| Total | $60.93 avg | 27,170 | $1.7M | 100% |
| Filing → |
| PTCT | SELL | 2023-01-12 | $257K | — | Filing → |
| PTCT | SELL | 2023-01-11 | $160K | — | Filing → |
| PTCT | SELL | 2022-06-09 | $11K | — | Filing → |